Pneumococcal conjugate vaccine

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

Rheumatoid ArthritisEffectivenessProspectiveMalnutritionImmunity

181 competitors in Rheumatoid Arthritis

#DrugCompanyPhaseTrials

1

Pneumococcal conjugate vaccine

Novartis

Phase 3

12

Actos

Takeda

Preclinical

23

Celexa

AbbVie

Preclinical

14

Voltaren

Novartis

Preclinical

—5

Cataflam

Novartis

Preclinical

—6

Plaquenil

Jazz Pharmaceuticals

Preclinical

—7

Vibramycin

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Preclinical

28

Velcade

SShilpa Grover, MD, MPH

Preclinical

29

Vancocin

HHikma Pharmaceuticals LLC

Preclinical

110

Solu-Medrol

MMassachusetts Eye and Ear Infirmary

Preclinical

—Show 24 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Immunogenicity6 trials

Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Children, Older Infants and Infants

Completed·Novartis·Phase 2·NCT01437267·120 enrolled

Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine (Bio Farma) in Adults and Children (Phase I)

Completed·PPT Bio Farma·Phase 1·NCT03109600·100 enrolled

The Safety, Tolerability, and Immunogenicity Profiles of a Single Dose of V114, PNEUMOVAX® 23, or PREVNAR 13® in Adults 50 Years of Age or Older (V114-002)

Completed·Merck & Co.·Phase 2·NCT01513551·692 enrolled

Show 3 more trials

Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adults, Children, Older Infants and Infants

Completed·Novartis·Phase 2·NCT01229176·200 enrolled

Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine Candidate in Healthy Adults (19-49 Years)

Completed·Sanofi·Phase 1·NCT06698198·175 enrolled

Evaluation of the Immunogenicity and Reactogenicity of a Pneumococcal Conjugate Vaccine in Healthy Adults

Completed·PPublic Health England·Phase 2·NCT00197821·611 enrolled

Vaccination2 trials

Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants

Completed·Novartis·Phase 3·NCT00806195·7,744 enrolled

Pneumococcal Conjugate Vaccination in HIV in Comparison to Polysaccharide Vaccine Boosting

Completed·HHenry M. Jackson Foundation for the Advancement of Military Medicine·Phase 3·NCT00622843·275 enrolled

Rheumatoid Arthritis1 trial

Vaccination Against Pneumococcal in Naïve Abatacept Rheumatoid Arthritis Patients

Completed·UUniversity Hospital, Montpellier·N/A·NCT02547493·80 enrolled

Immune Response1 trial

Targeting of Immune Response After Pneumococcal Vaccination

Completed·HHelsinki University Central Hospital·Phase 4·NCT01402245·42 enrolled

Clinical Trial1 trial

A Phase I Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine and 14-valent Pneumococcal Conjugate Vaccine in Adults

Completed·LLG Life Sciences·Phase 1·NCT02892812·63 enrolled

5 more indications

Immunity1 trial

Optimizing Cellular and Humoral Immunity by Vaccinating With PCV13 Before and After CAR-T Therapy

Active, not recruiting·HH. Lee Moffitt Cancer Center and Research Institute·Phase 2·NCT04745559·26 enrolled

Prospective1 trial

Multicenter Prospective Evaluation of the Incidence and Serotyes of Invasive Pneumoccocal Disease (IPD) Among Children Below 5 Years

Unknown status·KKing Saud University·N/A·NCT00843895·400 enrolled

Children1 trial

Safety and Local Tolerability of Prevenar in Indian Children

Completed·Pfizer··NCT00488800·1,000 enrolled

Malnutrition1 trial

Opportunistic Pneumococcal Immunisation Trial in MALnutrition

Not yet recruiting·NNick Fancourt·Phase 4·NCT06817421·214 enrolled

Effectiveness1 trial

Evaluating the Effectiveness of a Pneumococcal Immunisation Campaign in a Camp for Internally Displaced People

Active, not recruiting·LLondon School of Hygiene and Tropical Medicine·Phase 4·NCT04945681·2,882 enrolled

Details

Drug Info

Related News